Bora Pharmaceuticals Featured in Biopharma Reporter – How Bora is moving into biologics and attempting to crack North America

In this article, Bora discusses its expansion efforts and plans to provide services in the United States. In the large molecule space, Bora offers comprehensive services from the development of mammalian cell lines through cGMP production of drug substance.

Read the article

Please share this content with others who may benefit from it.

← Older Content Newer Content →

You may also be interested in

Bora Pharmaceuticals unveils eye-opening new facility for Ophthalmic manufacturing

by Brinette Holdren | Jul 31, 2023 | News and Events

Taiwan, 31st July 2023: Bora Pharmaceuticals, a leading contract development and manufacturing organization (CDMO), is pleased to announce the...

Bora Pharmaceuticals is Awarded Outstanding Company of the Year at Bio-Asia Taiwan 2023

by Brinette Holdren | Jul 20, 2023 | News and Events

Bora has been awarded "Outstanding Company of the Year" by an independent panel of international judges during Bio-Asia Taiwan exhibit taking place...

« Older Entries

Next Entries »

Bora Pharmaceuticals Featured in Biopharma Reporter – How Bora is moving into biologics and attempting to crack North America

Please share this content with others who may benefit from it.

You may also be interested in

Bora Pharmaceuticals unveils eye-opening new facility for Ophthalmic manufacturing

Bora Pharmaceuticals is Awarded Outstanding Company of the Year at Bio-Asia Taiwan 2023

Recent Posts

Stay Connected